Overall Technical outlook

Price Summary

On 2026-04-09, Glenmark Pharmaceuticals Limited's stock opened at 2173.5, spiked to 2186.2, declined to 2142.0, and closed -0.2% down at 2169.1, with 612813 shares traded.
In the past year, the highest stock price was 2272.7, and the lowest was 0.0.
12 analysts forecast that the price of GLENMARK will range from 1500.0 to 2735.0, with an average expected price near 2192.6667.

Technicals

Support and Resistance: The current price of 2169.1 for GLENMARK finds support at 2136.7 and resistance at 2272.7. These levels define a range in which the price might oscillate, with 2136.7 as a potential support and 2272.7 as a resistance level.
GLENMARK supportResistance 5a1351
Support/Resistance for GLENMARK


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for GLENMARK. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
GLENMARK aroon 5a1351
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
GLENMARK bbands 5a1351
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR continues its bearish trend, setting a resistance level that could prevent significant upward movement for GLENMARK. This resistance suggests that the market may struggle to overcome bearish forces, keeping upward momentum in check.
GLENMARK psar 5a1351
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The STOCHASTIC is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
GLENMARK stoch 5a1351
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The moving averages are positioned to support a bullish trend, reinforced by the upward sloping 20-50-100 aggregates. This alignment suggests that the market is gaining strength, potentially leading to ongoing gains. Traders might interpret this as a signal to enter or maintain their positions in anticipation of continued upward movement.
GLENMARK trippleSMA 5a1351
Tripple SMA chart for Glenmark Pharmaceuticals Limited


To make the most of a company's technical analysis, it's important to start with an understanding of its fundamentals. These include profitability, cash flow, and competitive positioning. Additionally, the industry in which the company operates plays a critical role, as trends and external factors can influence its market performance. By considering both the company's internal fundamentals and the external industry environment, more meaningful and accurate conclusions can be drawn from the technical data.